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In Brief
ZFC3H1 targets pA+ RNA for decay by the
nuclear RNA exosome. Garland et al.
report a disruptive relationship between
excess RNA and PRC2 upon depletion of
ZFC3H1 in mouse ESCs. In such
conditions, RNA is bound by PRC2
components, which show reduced
binding to chromatin and fellow PRC2
proteins.
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Pluripotent embryonic stem cells (ESCs) constitute
an essential cellular niche sustained by epigenomic
and transcriptional regulation. Any role of post-tran-
scriptional processes remains less explored. Here,
we identify a link between nuclear RNA levels, regu-
lated by the poly(A) RNA exosome targeting (PAXT)
connection, and transcriptional control by the poly-
comb repressive complex 2 (PRC2). Knockout of
the PAXT component ZFC3H1 impairs mouse ESC
differentiation. In addition to the upregulation of
bona fide PAXT substrates, Zfc3h1/ cells abnor-
mally express developmental genes usually
repressed by PRC2. Such de-repression is paralleled
by decreased PRC2 binding to chromatin and low
PRC2-directed H3K27 methylation. PRC2 complex
stability is compromised in Zfc3h1/ cells with
elevated levels of unspecific RNA bound to PRC2
components. We propose that excess RNA hampers
PRC2 function through its sequestration from DNA.
Our results highlight the importance of balancing nu-
clear RNA levels and demonstrate the capacity of
bulk RNA to regulate chromatin-associated proteins.
INTRODUCTION
Embryonic stem cells (ESCs) are distinguished by their dual abil-
ity to self-renew and differentiate, both of which require tight reg-
ulatory control. ESC pluripotency is maintained by a complex
molecular network centered around key transcription factors
(TFs), including OCT4, SOX2, NANOG, and KLF2 (Morey et al.,
2015; Takahashi and Yamanaka, 2006; Zhou et al., 2007). In
addition, epigenetic mechanisms establish and maintain
specialized chromatin through DNA methylation and histone
modifications to allow the activation and repression of genes1800 Cell Reports 29, 1800–1811, November 12, 2019 ª 2019 The A
This is an open access article under the CC BY-NC-ND license (http://during development (Bibikova et al., 2008; Chen and Dent,
2014). In consequence, perturbation of DNA methyltransferases
(DNMTs) or chromatin repressive complexes, for example, can
disrupt mammalian development through the dysregulation of
normal gene expression programs (Laugesen and Helin, 2014;
Smith and Meissner, 2013).
The exit of ESCs from pluripotency requires concerted
silencing of pluripotency factors and activation of lineage-
specific genes (Loebel et al., 2003). A key player here is the
polycomb repressive complex 2 (PRC2), which catalyzes the for-
mation of facultative heterochromatin via trimethylation of lysine
27 on histone 3 (H3K27me3). PRC2 is dispensable for the main-
tenance of self-renewal in ESCs but functions to prevent
inappropriate transcriptional activation of lineage-specific differ-
entiation factors. These include highly conserved homeobox
(HOX) factors, which are crucial for regulating axial patterning
in development (Laugesen and Helin, 2014; Pearson et al.,
2005), among other developmentally associated TFs that specify
cell fate. In ESCs, these genes are repressed through a combina-
tion of transcriptional and epigenetic control requiring PRC2 and
H3K27me3 (Mallo and Alonso, 2013). Furthermore, PRC2 is
crucial for cell fate transitions during development from ESCs,
where knockouts (KOs) of core complex components EZH2,
SUZ12, and EED result in a block in differentiation (Chamberlain
et al., 2008; Pasini et al., 2007; Shen et al., 2008).
Although research on ESC regulation has focused predomi-
nantly on transcriptional or epigenetic control, a role of post-
transcriptional events, including their putative coupling to
transcriptional control, has been less explored. A proper balance
of RNA processing and decay ensures homeostasis, whereby
different steps in gene regulation buffer one another to maintain
a stable expression profile within cell types (for recent reviews
see Schmid and Jensen, 2018; Timmers and Tora, 2018). Conse-
quently, malfunction of nuclear RNA decay pathways are there-
fore linked to developmental disorders and human disease
(Corbett, 2018). With improved sequencing technologies, the
complexity of the non-protein-coding genome has been re-
vealed (Carninci et al., 2005; Djebali et al., 2012). Functional rolesuthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
A B C
D
E F
G
Figure 1. Zfc3h1/ Cells Display Defects in EB Differentiation
(A) Schematic representation of the nuclear exosome complex (EXO13) and its PAXT connection. Question marks denote yet-to-be-defined PAXT components.
(B) Western blotting analysis of WT and three independent Zfc3h1/ cell lines (#1–#3). Blots were probed with the indicated PAXT-related antibodies and actin
(ACTB) as a loading control.
(C) qRT-PCR analysis of the indicated PAXT targets from total RNA isolated fromWT andZfc3h1/ cell lines. Primers were designed to span exon-exon junctions
in order to amplify spliced host gene transcripts. Results are shown relative to Rplp0 mRNA (RPO) and normalized to average WT values. Columns represent
average values of technical triplicates per sample, with error bars denoting SD. Individual data values from replicates are indicated as points.
(D) Phase contrast microscopy images of WT and Zfc3h1/ (#1–#3) colonies after 8 days of EB induction. Scale bars denote 200 mm.
(legend continued on next page)
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have emerged for long non-coding RNAs (lncRNAs), which form
ribonucleoprotein (RNP) complexes capable of regulating
various stages of gene expression (Geisler and Coller, 2013;
Rinn andChang, 2012), including themaintenance of ESCplurip-
otency and differentiation (Guttman et al., 2011; Luo et al., 2016).
Levels of lncRNAs in eukaryotic nuclei are tightly regulated by
RNA decay systems, which consequently must affect biological
processes regulated by such transcripts. Furthermore, it has
been shown that many key regulators of gene expression also
have RNA binding activity (Hendrickson et al., 2016; Khalil
et al., 2009). PRC2, for example, binds promiscuously to RNA
both in vitro and in vivo, with all core components (EZH2,
SUZ12, and EED) contributing to varying degrees (Cifuentes-Ro-
jas et al., 2014; Davidovich et al., 2013; Zhao et al., 2008, 2010).
The function of PRC2-RNA binding is not fully understood, but
results have suggested roles of both transcript-mediated recruit-
ment and eviction of PRC2 to and from chromatin (Davidovich
et al., 2013; Kaneko et al., 2013; Rinn et al., 2007; da Rocha
et al., 2014).
The RNA exosome is an essential 30-50 ribonucleolytic com-
plex involved in the regulation of the majority of nuclear tran-
scripts (Kilchert et al., 2016; Mitchell et al., 1997; Schmid and
Jensen, 2008). Assessing possible links between transcription
regulation and the post-transcriptional balancing of RNA levels,
the nuclear exosome stands out with its global activity in the pro-
cessing of precursor RNAs and its ability to efficiently remove
transcriptional by-products and otherwise nuclear retained
RNA (Schmid and Jensen, 2018). To facilitate recognition and
targeting of its plethora of transcript targets, the nuclear exo-
some associates with adaptor complexes; that is, two nucleo-
plasmic decay pathways are guided by the nuclear exosome
targeting (NEXT) complex and the poly(A) exosome targeting
(PAXT) connection, respectively (Lubas et al., 2011, 2015; Meola
et al., 2016; Silla et al., 2018). NEXT and PAXT share a common
subunit in the RNA helicase MTR4, which connects these adap-
tors to the exosome. PAXT is also composed of a large zinc
finger protein, ZFC3H1, which bridges MTR4 to the nuclear
poly(A) binding protein (PABPN1), aiding the targeting of polya-
denylated (pA+) nuclear RNAs for exosome-mediated decay
(Beaulieu et al., 2012; Bresson and Conrad, 2013; Meola et al.,
2016; Ogami et al., 2017).
At steady state, lncRNA levels in mammalian cells are gener-
ally low, with estimates suggesting that less than 1,000 lncRNAs
are present in more than one copy per cell (Djebali et al., 2012;
Seiler et al., 2017). Thus, most lncRNAs are stoichiometrically
inferior to their putative protein effectors, often weakening the
associated mechanistic models claiming function of individual
lncRNAs. The abundance of lncRNAs is regulated through nu-
clear RNA decay pathways and is considerably enriched upon
removal of exosome components (Lubas et al., 2011; Meola
et al., 2016; Silla et al., 2018). Manipulating PAXT activity,(E) qRT-PCR analysis of the indicated mRNAs from total RNA isolated from thr
induction of EB differentiation (day 0 [D0] to day 10 [D10]). Results are displayed
(F) Western blotting analysis of extracts prepared from WT and Zfc3h1/ (#1) ce
with the indicated antibodies with vinculin (VCL) as a loading control.
(G) qRT-PCR analysis and data representation as described in (E) but using p
ectoderm).
1802 Cell Reports 29, 1800–1811, November 12, 2019through the depletion of ZFC3H1, therefore allows an approach
to study the general effects of excess pA+ RNA in the nucleus.
Here, we establish a functional link between PAXT activity and
transcriptional control mediated by PRC2. Zfc3h1/ cells are
unable to differentiate and exhibit phenotypes reminiscent of
cells deficient for PRC2 activity. Consistently, normal PRC2
function is impaired in Zfc3h1/ cells and we provide evidence
that this is due to PRC2 binding to stabilized RNAs. Our results
highlight the importance of controlling nuclear RNA levels during
key regulatory stages of ESC development and imply that mod-
ulation of bulk RNA levels is a potent way of lncRNA-mediated
transcription regulation.
RESULTS
Zfc3h1/ Cells Exhibit Defective Embryoid Body
Differentiation
To assess the role of exosome-mediated decay of nuclear pA+
RNAs in ESC pluripotency and differentiation, we used
CRISPR/Cas9 to generate homozygous KOs of the PAXT
component ZFC3H1 (Figure 1A). Zfc3h1 was specifically tar-
geted because MTR4 and PABPN1 also reside in alternative nu-
clear complexes. Three biologically independent Zfc3h1/ ESC
lines with disrupted Zfc3h1 ORFs were derived from single-cell
KO clones (Figure S1A). In agreement with our previous observa-
tions in human cells, the expression of other known PAXT-
related (Figure 1B) and exosome-related (Figure S1B) proteins
was unaffected by ZFC3H1 depletion (Meola et al., 2016). Still,
PAXT-mediated RNA decay was disrupted, which resulted in
an approximately 2-fold accumulation of total nuclear pA+ RNA
(Figure S1C), including spliced small nucleolar RNA (snoRNA)
host gene (Snhg) lncRNAs (Meola et al., 2016; Figure 1C).
Zfc3h1/ cells were viable under 2i+LIF growth conditions,
which selects against cellular differentiation, and appeared
morphologically similar to wild-type (WT) cells (Figure S1D).
Furthermore, expression of the key pluripotency TFs NANOG,
ESRRB, KLF2, SOX2, and OCT4 was not perturbed (Figure S1E),
which suggests that the absence of ZFC3H1 does not affect the
self-renewal properties of ESCs. Strikingly, however, when cells
were transferred from 2i+LIF conditions to serum-LIF media on
low-attachment plates to allow the spontaneous development
of embryoid bodies (EBs) (Figure S1F), Zfc3h1/ cells displayed
morphological phenotypes, suggesting difficulties with normal
differentiation. Specifically, after 8 days of EB induction,
Zfc3h1/ KO cells still retained an ESC-like morphology, with
smaller rounded colonies and a lack of differentiated cell types
(Figure 1D). The cells also showed a lack of cystic EBs, cavities
that normally form during differentiation because of programmed
cell death, but instead remained as solid aggregates, apparent
as dark spots on microscopy images (Figure 1D). Finally, be-
tween 7 and 8 days of differentiation, WT cells normally developee independent WT or Zfc3h1/ cell lines taken at the indicated times after
as in (C).
lls taken at the indicated times after EB induction (D0–D7). Blots were probed
rimers against lineage markers (Gata4, endoderm; Tbxt, mesoderm; Nkx2-5,
A B
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Figure 2. PRC2 Target Genes Are Upregulated in Zfc3h1/ ESCs
(A) Differential gene expression analysis of RNA-seq data from Zfc3h1/ versus WT cells after 7 days of EB induction shown as an MA plot. The y axis shows
Zfc3h1/ versus WT RNA-seq log2 FC. The x axis shows average normalized expression as log2 counts per million (CPM) values across all biological replicates.
Each dot indicates a gene, and blue/yellow color denotes significant differential expression (edgeR FDR < 0.05). Red lines denote log2 FC > 1, <1. Upregulated
genes involved in pluripotency and downregulated genes involved in differentiation are highlighted.
(B) MA plot as in (A) but for undifferentiated (D0) Zfc3h1/ versusWT cells. Values are averages of twoWT and three Zfc3h1/ biological replicates. Upregulated
genes highlighted indicate PRC2 target genes involved in developmental processes.
(C) Bar plot of upregulated (log2 FC > 0.5) gene types in D0 Zfc3h1
/ cells. GENCODE RNA biotypes are color coded as indicated, and numbers of affected
genes are shown in parenthesis.
(legend continued on next page)
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spontaneous beating colonies, indicative of cardiomyocyte for-
mation (Doetschman et al., 1985), which was not observed up
to 10 days of EB induction of Zfc3h1/ cells.
We then collected samples across the EB differentiation time
course to analyze the expression of cell type-specific markers
(e.g., pluripotency TFs normally decrease rapidly when cells
differentiate). In contrast, Zfc3h1/ cells retained high expres-
sion of the pluripotency TFs OCT4, SOX2, ESRRB, and KLF2
at later stages of the time course as assessed by RNA and pro-
tein analyses (Figures 1E and 1F). qRT-PCR primers spanning
exon-intron (ExIn) borders of Oct4 and Nr0b1 pre-mRNAs
showed that intronic sequences were elevated in Zfc3h1/ cells
(Figure S1G), suggesting that these genes might be transcrip-
tionally upregulated. Finally, the expression of lineage-specific
markers was impaired in Zfc3h1/ cells, with little or no expres-
sion of endodermal, mesodermal, and ectodermal TFs (Fig-
ure 1G). Taken together, we conclude that Zfc3h1/ cells
show EB differentiation phenotypes and retain an expression
profile reminiscent of undifferentiated cells.
Transcripts from PRC2-Targeted Genes Are Enriched in
Zfc3h1/ Cells
To obtain a global impression of the disparities between WT and
Zfc3h1/ cells, sequencing of rRNA-depleted total RNA (RNA-
seq) was performed on samples harvested after 7 days (D7) of
EB induction. This time point was chosen because it showed
large gene expression differences between WT and Zfc3h1/
cells as measured by qRT-PCR (Figures 1E and 1G). In addition,
total RNA from ESC (D0) samples was sequenced to assess the
undifferentiated starting point of the experiment. Biological rep-
licates of RNA-seq libraries were overall highly correlated (Fig-
ures S2A and S2B). Differential expression (DE) analysis of D7
samples mirrored our qRT-PCR analyses: Zfc3h1/ cells dis-
played elevated expression of pluripotency-associated TFs
and decreased expression of germ layer-specific transcripts
(Figure 2A). This, in conjunction with the morphological pheno-
types, suggested that Zfc3h1/ cells are unable to exit from
the embryonic stem (ES) state and activate the normal genes
required to initiate differentiation. We surmised that this inability
to exit from pluripotency might be due to gene expression aber-
rancies in the D0 ES state disrupting normal progression into dif-
ferentiation pathways. Consistent with this notion, DE analysis
revealed higher levels of mRNAs encoding lineage-specific fac-
tors normally associated with differentiated cells in Zfc3h1/
versus WT D0 samples (Figure 2B). A large number of these up-
regulated lineagemarkers comprised TFs, includingHOX genes,
which are involved in early developmental processes (Pearson
et al., 2005). At first glance, such an expression profile would(D) Venn diagram showing overlap of upregulated (log2 FC > 0.5, FDR < 0.05) prot
versus WT cells. The numbers of genes in each set are shown.
(E) Relation between exonic and intronic read counts in Zfc3h1/ and Ezh1//E
calculated using edgeR in introns (x) and exons (y) of 331 intron-containing genes
the intersect in D), with a diagonal reference line (y = x). Dark green dots indicate
(F) Upper panel: GenomeBrowser views of RNA-seq data fromWT and Zfc3h1/
read densities at + and – strands as indicated. RefSeq gene models and mm10 g
used in the lower panel. Lower panel: qRT-PCR analysis ofHOX gene pre-mRNAs
Results are shown relative to GAPDH mRNA values and normalized to average W
1804 Cell Reports 29, 1800–1811, November 12, 2019seemingly contrast our observation that Zfc3h1/ ESCs appear
morphologically similar to WT ESCs. However, although exit
from pluripotency requires the expression of developmental
TFs, this must occur concomitant with suppression of pluripo-
tency TFs, which predominantly define the cellular state of
ESCs (Young, 2011). Moreover, the selective pressure of the
2i/LIF culture condition maintains the pluripotent state by block-
ing MEK and GSK activity and activating the STAT3 pathway
(Wray et al., 2010; Ying et al., 2008).
Nevertheless, abnormal expression of developmental genes in
the Zfc3h1/ ESCs indicated a general deregulation of differen-
tiation-associated genes. In WT ESCs, these genes are normally
repressed in an inactive chromatin environment highly decorated
with H3K27me3 (Mallo and Alonso, 2013). Furthermore, the
repression of pluripotency genes during differentiation is regu-
lated by H3K27me3 (Obier et al., 2015; Pasini et al., 2007). As
this histone mark is solely catalyzed by the PRC2 complex, we
compared the gene expression profile of Zfc3h1/ ESCs with
published PRC2 KO (Ezh1//Ezh2/) RNA-seq data derived
from the same parental mouse ESC line (Højfeldt et al., 2018).
Of the 1,804 upregulated transcripts in the Zfc3h1/ D0 sam-
ples (log2 fold change [FC] > 0.5, false discovery rate [FDR] <
0.05, edgeR), approximately 25% could be designated as non-
coding RNAs (ncRNAs) (Figure 2C), including known PAXT tar-
gets upregulated because of their diminished decay, while
75% of cases were protein coding. Almost one-third of the
latter transcripts showed a significant (p < 1.1e-18, hypergeo-
metric test) overlap with transcripts upregulated in PRC2 KO
cells (Figure 2D). For these shared transcripts, exonic and in-
tronic reads were evenly upregulated in the Zfc3h1/ D0 data
(Figure 2E), suggesting that increased mRNA levels were based
on increased transcription. This was validated by qRT-PCR anal-
ysis of upregulated HOX transcripts using ExIn-specific primers
on chromatin-associated RNA to enrich for pre-mRNA (Fig-
ure 2F). We conclude that Zfc3h1/ ESCs have higher levels
of transcripts derived from a subset of PRC2 target loci, and
these genes appear to be more transcriptionally active in the
absence of PAXT.
SUZ12 Chromatin Occupancy and H3K27me3 Levels
Are Decreased in Zfc3h1/ Cells
As Zfc3h1/ cells displayed increased expression of transcripts
also upregulated in the absence of PRC2, we investigated the
status of the PRC2 complex in the Zfc3h1/ background.
Expression of its core components, EZH2, SUZ12, and EED,
was unaffected by the absence of ZFC3H1 (Figure S3A). There-
fore, we decided to conduct chromatin immunoprecipitation
sequencing (ChIP-seq) on the three Zfc3h1/ cell lines, alongein-coding genes in Zfc3h1/ and Ezh1//Ezh2/ undifferentiated (D0) cells
zh2/ upregulated genes. Axes show log2 FC of normalized RNA-seq reads
upregulated in both Zfc3h1/ and Ezh1//Ezh2/ RNA-seq datasets (from
FDR < 0.05, and light green dots indicate FDR < 0.05 for intronic reads.
D0 (#1) libraries at the indicatedHOX gene loci. Tracks showWT and Zfc3h1/
enome coordinates are shown, together with ExIn qRT-PCR primer amplicons
from chromatin-associated RNA isolated fromWT and Zfc3h1/ (#1) D0 cells.
T values. Results are displayed as in Figure 1C.
A B
DC
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Figure 3. SUZ12 DNA Occupancy and H3K27me3 Levels Are Decreased in Zfc3h1/ Cells
(A) MA plots showing global changes in H3K27me3 and SUZ12 ChIP-seq densities in Zfc3h1/ versus WT cell lines. Dots indicate sliding genome windows,
where color intensity indicates the density of overlapping points. Y axes show log2 FC Zfc3h1
/ versusWT normalizedChIP signal, and x axes show average log2
ChIP signal, all from three independent biological replicates.
(B) Boxplot distributions of log2 FC Zfc3h1
/ versusWT normalized H3K27me3 and SUZ12 ChIP signals on regions centered on 3678 SUZ12 peaks identified in
WT cells.
(C) Average SUZ12 ChIP-seq signals for Zfc3h1/ and WT cell lines in regions centered on the SUZ12 peaks as in (B). Zfc3h1/ ChIP data are the average of
three biological replicates.
(D) As in (C) but for H3K27me3 signal from regions centered on the SUZ12 peaks from (B).
(E) Heatmap representation of the relation between SUZ12 ChIP-seq, H3K27me3 ChIP-seq, and RNA-seq log2 FC in Zfc3h1
/ versus WT cells. Columns
represent SUZ12 peaks identified in WT cells (N = 1,485), sorted after SUZ12 Zfc3h1/ versus WT log2 FC. Rows correspond to SUZ12 ChIP-seq, H3K27me3
ChIP-seq, and RNA-seq Zfc3h1/ versus WT log2 FC values.
(legend continued on next page)
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with the parental WT cell line, using antibodies specific for
H3K27me3 and SUZ12. Zfc3h1/ cells displayed reduced
H3K27me3 levels and SUZ12 DNA occupancy in comparison
with WT cells (Figures 3A, S3B, and S3C). These reductions
were generally found in regions with high average signal, and
the effect on H3K27me3 levels was substantially stronger than
the effect on SUZ12 binding (Figure 3B). Still, while H3K27me3
levels were clearly decreased in Zfc3h1/ cells, they were not
abolished (average reduction to 75% versus WT, Figure S3D;
as opposed to previously reported KOs of different PRC2 com-
ponents in which H3K27 methylation is absent, Højfeldt et al.,
2018; Pasini et al., 2007; Shen et al., 2008; see Discussion).
PRC2-bound regions, defined by SUZ12 ChIP-seq peaks in
WT cells, had significantly (p < 2.2e-16, one-sided Mann-Whit-
ney test) lower average SUZ12 and H3K27me3 occupancy in
Zfc3h1/ conditions (Figures 3B–3D). Moreover, regions
depleted for PRC2 and H3K27me3 in Zfc3h1/ cells showed
a concomitant increase in RNA expression (Figure 3E), which
was equally elevatedwhether exonic or intronic readswere inter-
rogated (Figure 3F).
ChIP-seq analyses of active and primed chromatin modifi-
cations (H3K4me1, H3K4me3, H3K27ac) were also carried
out in WT and Zfc3h1/ cells. Genes depleted for SUZ12
and H3K27me3 ChIP signals had a marked increase in
H3K27ac levels, concordant with increased RNA transcription
(Figures 3G and S3F). We also obtained low-sequence depth
RNA polymerase II (RNAPII) ChIP-seq data, which showed
increased occupancy at select PRC2 target genes in
Zfc3h1/ cells (Figure S3H). Altogether, this fits the notion
that PRC2 loci are more transcriptionally active in the absence
of normal polycomb-mediated repression via H3K27me3. We
conclude that recruitment of SUZ12 to PRC2 target genes is
reduced in Zfc3h1/ cells, resulting in loss of H3K27me3 at
these regions and abnormal RNA expression due to increased
transcription.
Decreased PRC2 Complex Integrity in Zfc3h1/ Cells
The discovered correlation between PAXT-mediated RNA decay
and PRC2-mediated transcriptional repression is unprece-
dented. We therefore sought to address how impaired PRC2
function in Zfc3h1/ cells relates to the primary phenotype of
stabilized nuclear pA+ RNAs. As mentioned above, steady-state
levels of PRC2 components remain unchanged in Zfc3h1/
cells (Figures S3A, 4A, and 4B, ‘‘Inputs’’). However, co-immuno-
precipitation (coIP) analyses of SUZ12 (Figures 4A and S4A) or
EZH2 (Figures 4B and S4B) from whole-cell lysates revealed
their reduced binding to the remaining PRC2 core. Similar effects
were observed when conducting IPs from nuclear extracts (Fig-
ures S4C and S4D). Such weakened PRC2 complex formation in
Zfc3h1/ cells was further supported by analyzing the sedimen-
tation of PRC2 components through glycerol gradients: Although(F) Correlation of Zfc3h1/ versusWT log2 FC RNA-seq signal in intronic versus e
0 in Zfc3h1/ versus WT overlapping with SUZ12 peaks that show log2 FC > 0 in
RNA-seq in exonic (y) and intronic (x) regions of these transcripts.
(G) GenomeBrowser views of four PRC2 target genes (Hoxd8,Sox21,Gsc, andNe
SUZ12 ChIP-seq data as well as RNA-seq data from WT and Zfc3h1/ (#1) cell
models are based on RefSeq. Genome coordinates (mm10) are indicated for eac
1806 Cell Reports 29, 1800–1811, November 12, 2019the overall protein distribution and sedimentation of loading con-
trols remained unchanged (Figures S4E and S4F), SUZ12 and
EZH2 showed a marked shift from high-molecular weight frac-
tions toward lower molecular weight fractions of the gradient
derived from Zfc3h1/ lysates (Figures 4C and 4D). The distri-
bution of EED was more dispersed throughout the gradient
from WT lysates but still showed a shift toward lower fractions
in Zfch3h1/ samples (Figure S1F). Despite these shifts, a frac-
tion of PRC2 sedimented normally in Zfc3h1/ samples and
consistently remained bound in coIPs (Figures 4A–4D and
S4F). Together, these analyses suggested that the PRC2 com-
plex is partially compromised in Zfc3h1/ cells, which could
be further elaborated by subcellular fractionation of WT and
Zfc3h1/ cells, giving rise to a slight, but significant, shift in
the distribution of SUZ12, EZH2 and EED from chromatin-bound
to nucleoplasmic fractions (Figures S4G and S4H). Previous re-
ports demonstrated that the complete loss of SUZ12 or EED re-
sults in reduced levels of the remaining PRC2 core components
(Højfeldt et al., 2018; Montgomery et al., 2005; Pasini et al.,
2007), suggesting that PRC2 complex stability depends on the
interactions of all core proteins. In contrast, here we found lower
levels of the PRC2 complex in Zfc3h1/ cells despite normal
expression of SUZ12, EZH2, and EED.
Given the RNA accumulation observed in the absence of PAXT
(Meola et al., 2016; Figures 1C, 2C, and S1C) and the RNA-bind-
ing properties of PRC2, we hypothesized that accumulation of
PAXT targets could contribute to PRC2 disruption, linking the
primary Zfc3h1/ phenotype with a secondary PRC2 pheno-
type. Hence, we carried out native IPs of SUZ12 and EZH2, using
lysates prepared from WT and Zfc3h1/ ESCs, and measured
the amount of co-isolated RNA. From WT cells, EZH2 IPs
showed a greater enrichment of RNA over SUZ12 IPs and the
IgG control (Figure 4E), which is in agreement with EZH2 being
the PRC2 component with the strongest capacity for RNA bind-
ing (Cifuentes-Rojas et al., 2014). However, elevated RNA levels
were isolated from both SUZ12 and EZH2 IPs of Zfc3h1/
versus WT cell lysates. Thus, concomitant with complex disrup-
tion, more RNA was bound to PRC2 components upon PAXT
depletion. RNA isolated from SUZ12 and EZH2 IPs was
sequenced (RIP-seq) to interrogate any differences in PRC2-
bound transcripts from WT versus Zfc3h1/ ESCs. Consistent
with previous native RIP-seq analysis of PRC2 components (Da-
vidovich et al., 2013; Khalil et al., 2009; Zhao et al., 2010), we
found that EZH2 and SUZ12 showed promiscuous binding to
both protein-coding RNA and ncRNA. In Zfc3h1/ samples,
both SUZ12 and EZH2 RIPs revealed PAXT targets, including
pA+ nuclear lncRNAs (Figure S5A), along with transcripts from
de-repressed PRC2 target genes (Figure S5B). However, for
transcripts upregulated in Zfc3h1/ ESCs, there was no signif-
icant enrichment of coding RNAs or ncRNAs over the input
samples (Figure S5C). Furthermore, there was no specificxonic regions. Points displayed are intron-containing transcripts with log2 FC >
Zfc3h1/ ChIP-seq data (N = 365). Axes show Zfc3h1/ versus WT log2 FC
fm). Displayed tracks include H3K4me1, H3K4me3, H3K27ac, H3K27me3, and
lines. RNA-seq tracks on both strands are shown (+ and –, respectively). Gene
h panel.
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Figure 4. Decreased PRC2 Complex Integ-
rity in Zfc3h1/ Cells
(A) Western blotting analysis of SUZ12 IPs from
lysates of WT and Zfc3h1/ cells. IgG IPs were
included as a negative control. Input and IP sam-
ples were probed using the indicated antibodies.
Actin (ACTB) was used as an input loading control.
(B) Western blotting analysis as in (A) but for EZH2
IPs. Tubulin (TUBA1B) was used as an input
loading control.
(C) Glycerol gradient analysis of SUZ12 sedimen-
tation in extracts from WT and Zfc3h1/ cells.
Left panel: western blotting analysis of 10%–50%
glycerol gradient fractions. Right panel: quantifi-
cation of SUZ12 signals from the western blotting
analysis. Fraction values were normalized to input
sample signals. Points show the average signal
from duplicate samples and error bars denote the
SD. A smoothed curve was plotted to indicate the
distribution of signal throughout the gradient.
(D) As in (C), but showing EZH2 distribution
throughout the gradients.
(E) Quantification of RNA isolated from IgG,
SUZ12, or EZH2 IPs of WT or Zfc3h1/ cell ly-
sates. Values were normalized to input samples.
Columns represent the average value of technical
triplicates per sample, with error bars denoting
SD. Individual data values from technical tripli-
cates are indicated as points.
(F) Western blotting analysis of SUZ12 IPs from
WT or Zfc3h1/ lysates following either mock or
RNaseA treatment. Input and IP samples were
probed as in (A) but with vinculin (VCL) as an input
loading control.
(G) Summary depicting the suggested functional
consequences of Zfc3h1/ KOs in ESCs. In the
absence of PAXT-mediated RNA decay, nuclear
pA+ transcripts are stabilized. Excess RNA binds
and out-titrates PRC2 from chromatin, and the
interaction between complex subunits is dis-
rupted. PRC2-depleted regions show reduced
H3K27me3 levels and correlate with increased
transcription at affected loci.enrichment of RNAs upregulated in Zfc3h1/ ESCs only, in both
Zfc3h1/ and Ezh1/Ezh2/ ESCs (Højfeldt et al., 2018) or for
transcripts upregulated at SUZ12-depleted loci (Figure S5D).
This suggests that increased nuclear RNA levels in Zfc3h1/
ESCs leads to more RNA binding to PRC2 components with
no general specificity.
To address whether the disruption of PRC2 in Zfc3h1/ cells
was indeed dependent on increased RNA levels, we repeated
the SUZ12 coIP analyses using cell extracts that were either
mock or RNaseA treated. In the presence of RNase, SUZ12
IPs from Zfc3h1/ extracts recapitulated the coIP efficiency of
equivalent WT extracts (Figures 4F and S5E). More bait protein
was generally pulled down in the RNase-treated samples, which
suggested that RNA already interfered with the IP inWT extracts,
but to a greater extent in Zfc3h1/ extracts. Taken together, we
propose that increased RNA binding weakens PRC2 complexformation, thereby decreasing its normal function, stability. and
recruitment to chromatin (Figure 4G; see Discussion).
DISCUSSION
The molecular decisions that govern correct progression
through cellular differentiation require a complex agreement of
checks and balances. Here, the transcriptional and epigenetic
profiles at the ESC stage are important starting points, whose
dysregulation may be deleterious for development. In the pre-
sent study, we discovered a link between excess nuclear RNA
and PRC2-mediated transcriptional control in ESCs, suggesting
an essential role of nuclear RNA turnover in cellular commitment
to differentiation.
Deletion of the nuclear exosome adaptor ZFC3H1 to some
extent phenocopies ESCs depleted for PRC2 components; cellsCell Reports 29, 1800–1811, November 12, 2019 1807
self-renew and appear morphologically similar to WT cells but
show a loss of H3K27me3, deregulation of PRC2 target genes,
and difficulty initiating differentiation (Boyer et al., 2006; Cham-
berlain et al., 2008; Pasini et al., 2007; Shen et al., 2008). In
contrast to PRC2-depleted cells, Zfc3h1/ ESCs retain a de-
gree of SUZ12 binding and H3K27me3 modification, which pre-
sumably explains the less severe deregulation of PRC2 target
genes. Still, the defect appears to be sufficient to restrict the
progression into differentiation. In agreement with previous
studies, we find that deregulation of PRC2 target genes results
in abnormal transcription of developmental genes (Boyer et al.,
2006; Lee et al., 2006). It would seem counterintuitive for ESCs
expressing developmental genes to retain self-renewal ability
and to lose the ability to differentiate upon induction of EB for-
mation. However, it has been suggested that the expression of
pluripotency TFs is sufficient for self-renewal and overrides any
abnormal expression of lineage markers (Chamberlain et al.,
2008). As cells exit pluripotency, PRC2 functions to silence
key maintenance factors such as Oct4, Sox2, and Nanog by
depositing H3K27me3 at their loci (Obier et al., 2015). With
PRC2 function decreased in Zfc3h1/ cells, this presumably
explains their retained transcriptional activity of pluripotency
TFs and block in differentiation (Figures 1E, 1F, and S1G).
Together this reiterates that PRC2 and, in turn, ZFC3H1 are
dispensable for self-renewal but are essential for the progres-
sion into differentiation (Chamberlain et al., 2008; Pasini et al.,
2007; Shen et al., 2008).
An RNA-binding ability of the PRC2 complex has been widely
documented, with suggested models for transcript-mediated
recruitment or eviction of PRC2 to or from DNA (Davidovich
et al., 2013; Kaneko et al., 2013; Rinn et al., 2007; da Rocha
et al., 2014). A primary phenotype of ZFC3H1 depletion is the
stabilization of nuclear pA+ RNAs (Meola et al., 2016; Ogami
et al., 2017; this study), which are, by nature, unstable and typi-
cally present only in trace amounts under normal conditions.
Through removing the targeting mechanisms for decay, this in-
creases the concentration of pA+ RNAs (Silla et al., 2018). Taken
together with increased binding of RNA to EZH2 and SUZ12 in
Zfc3h1/ cells, we therefore propose that increased transcript
levels negatively affect PRC2 function through its increased
RNA binding (Figure 4G). Previous studies initially suggested
that excess RNA can inhibit the methyltransferase activity of
EZH2 in vitro (Cifuentes-Rojas et al., 2014; Kaneko et al.,
2014), which was further elaborated to suggest that decreased
catalytic activity was due to RNA titrating PRC2 off nucleosomes
(Wang et al., 2017). This was supported by observations that
DNA- and RNA-binding capabilities of PRC2 are mutually exclu-
sive in vitro (Beltran et al., 2016; Wang et al., 2017). More
recently, an RNA-binding region was identified at an allosteric
regulatory region of PRC2 in close proximity to the methyltrans-
ferase region of EZH2, which is subsequently inhibited by RNA
binding (Zhang et al., 2019). It is therefore plausible that
increased nuclear RNA levels dually affect PRC2 function by
decreasing its catalytic activity aswell as its DNA-binding capac-
ity. We also find that the interaction between PRC2 subunits is
compromised in Zfc3h1/ cells with reduced binding between
core subunits in coIP and glycerol gradient assays (Figures
4A–4D). Such decreased interaction between SUZ12 and1808 Cell Reports 29, 1800–1811, November 12, 2019EZH2 may contribute to an explanation of the stronger loss of
H3K27me3 compared with SUZ12 ChIP-seq signal in Zfc3h1/
cells (Figure 3B); that is, residual SUZ12, uncoupled from EZH2,
may still bind DNA. In line with this, our ChIP and subcellular frac-
tionation data showed that a fraction of PRC2 components are
still associated with chromatin. This partial phenotype allows
us only to speculate at this point and will require further investi-
gation to understand the status of PRC2 complex proteins that
are still able to bind DNA. However, in support of this possibility,
the N-terminal region of SUZ12 recapitulates SUZ12-binding
patterns but lacks EZH2 interaction and thereby does not rescue
H3K27me3 activity (Højfeldt et al., 2018). The use of such mu-
tants, in combination with Zfc3h1/ cells and extended ChIP
datasets, might allow unpacking of the molecular basis behind
these observations.
Finally, we show that the disruption between core PRC2 sub-
units in Zfc3h1/ cell extracts can be rescued upon RNase
treatment (Figure 4F). These results echo previous data showing
that RNase treatment increases chromatin association of PRC2
in cells and, reciprocally, recombinant PRC2 can be titrated off
nucleosomes by increasing nuclear RNA levels (Beltran et al.,
2016). We propose that this antagonism is a general effect of
increased nuclear RNA, as we do not see specific enrichment
of particular transcripts in RIP-seq experiments: RNAs that are
upregulated in the Zfc3h1/ inputs are also upregulated in the
RIP data. This appears in line with previous findings, that the
RNA-binding capability of PRC2 is non-specific and promiscu-
ous in nature.
Although PRC2 has garnered considerable attention, RNA-
binding capacities have also been reported for other chromatin
regulators, including DNMTs, histone deacetylases (HDAC1),
chromatin remodeling proteins (ATRX), DNA demethylases
(TET1/2), and other histone methyltransferases (G9a) (Castella-
nos-Rubio et al., 2016; He et al., 2016; Hendrickson et al.,
2016; Holz-Schietinger and Reich, 2012; Li et al., 2018; Di Ruscio
et al., 2013; Sarma et al., 2014). Interestingly, RNA has been sug-
gested to have a regulatory function in a number of models,
either locally at specific loci or by more global mechanisms;
that is, similar to PRC2, RNA binding has been proposed to
sequester DNMT1 from transcriptionally active regions as a reg-
ulatory mechanisms to prevent DNA methylation at these loci (Di
Ruscio et al., 2013). Indeed, RIP experiments demonstrate that
SUZ12 and DNMT1 both tend to associate with the 50 ends of
RNA (Hendrickson et al., 2016), and both proteins have a greater
affinity for RNA over DNA (Di Ruscio et al., 2013; Wang et al.,
2017). RNA sequestering is also suggested in some disease
models in which lncRNAs are overexpressed and affect chro-
matin modifiers through their abnormal titration (Gupta et al.,
2010; Li et al., 2018; Merry et al., 2015; Prensner et al., 2013).
Taken together with our results, this highlights the importance
of maintaining a stable nuclear transcriptome through active
RNA decay to prevent off-target effects as a result of RNA accu-
mulation. Moreover, our results demonstrate the capacity of
changed bulk RNA levels to affect cellular transcription pro-
grams. Although dysregulation of PRC2 on a global level is
highlighted here, it is equally feasible that an unbalanced tran-
scriptome might affect the function of other bivalent chromatin/
RNA-binding proteins either locally or globally.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
PSRC2 (ZFC3H1) antibody Novus Biologicals Cat# NB100-68267; RRID:AB_2218116
ZFC3H1 antibody Sigma-Aldrich Cat# HPA-007151; RRID:AB_1846133
MTR4 (SKIV2L2) antibody Abcam Cat# ab70551; RRID:AB_1270701
PABPN1 antibody Abcam Cat# ab75855; RRID:AB_1310538
EXOSC4 (RRP41) antibody In house (Pruijn lab) Brouwer et al., 2001
DIS3 antibody Sigma-Aldrich Cat# HPA039281; RRID:AB_10795583
ZCCHC8 antibody Abcam Cat# ab68739; RRID:AB_1271512
ACTB (b-ACTIN) antibody Sigma-Aldrich Cat# A2228; RRID:AB_476697
NANOG antibody Cell Signaling Cat# 8822; RRID:AB_11217637
ESRRB antibody R+D Systems Cat# PP-H6705-00; RRID:AB_2100412
KLF2 antibody Millipore Cat# 09-820; RRID:AB_10807287
SOX2 antibody Santa Cruz Cat# sc-17320; RRID:AB_2286684
OCT4 antibody Abcam Cat# ab19857; RRID:AB_445175
VCL (VINCULIN) antibody Sigma-Aldrich Cat# V9131; RRID:AB_477629
SUZ12 antibody Cell Signaling Cat# 3737; RRID:AB_2196850
EZH2 antibody Cell Signaling Cat# 5246; RRID:AB_10694683
EZH2 antibody In house (Helin lab) AC22
EZH2 antibody Abcam Cat# ab195409
EED antibody In house (Helin lab) Bracken et al., 2003
SFPQ antibody Abcam Cat# ab50935; RRID:AB_882523
TUBA1B (a-TUBULIN) antibody Rockland Cat# 600-401-880; RRID:AB_2137000
RPB1 NTD antibody Cell Signaling Cat# 14958; RRID:AB_2687876
H3K27me3 antibody Cell Signaling Cat# 9733; RRID:AB_2616029
H3K27ac antibody Cell Signaling Cat# 8173: RRID:AB_10949503
H3K4me1 antibody Cell Signaling Cat# 5326; RRID:AB_10695148
H3K4me3 antibody Cell Signaling Cat# 9751; RRID:AB_2616028
H3 antibody Abcam Cat# ab1791; RRID:AB_302613
H4 antibody Millipore Cat# 05858; RRID:AB_390138
IgG Millipore Cat# PP64; RRID:AB_97852
Bacterial and Virus Strains
DH5a Chemically Competent Cells Prepared in lab N/A
Chemicals, Peptides, and Recombinant Proteins
GSK3 inhibitor (CHIR99021) Sigma-Aldrich Cat# SML1046
MEK1/2 inhibitor (PD0325901) Sigma-Aldrich Cat# PZ0162
N-2 Supplement Thermo Fisher Scientific Cat# 17502048
B-27 Supplement Thermo-Fisher Scientific Cat# 17504044
TRIZOL Reagent Thermo-Fisher Scientific Cat# 15596018
Lipofectamine 2000 Transfection Reagent Thermo-Fisher Scientific Cat# 11668019
Protein A Dynabeads Thermo-Fisher Scientific Cat# 10008D
Agencourt AMPure XP Beads Thermo-Fisher Scientific Cat# 10136224
Benzonase nuclease Millipore Cat# 70746
RNaseA Thermo-Fisher Scientific EN0531
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Critical Commercial Assays
RNeasy Mini Kit QIAGEN Cat# 74106
Dynabeads mRNA Purification Kit Thermo Fisher Scientific Cat# 61006
Taqman Reverse Transcription Reagents Thermo Fisher Scientific Cat# N8080234
Truseq Stranded Total RNA Library Prep Gold Kit Illumina Cat# 20020598
Subcellular Protein Fractionation Kit for Cultured Cells Thermo Fisher Scientific Cat# 78840
NEBNext Ultra II DNA Library Prep Kit for Illumina NEB Cat# E7645S
Deposited Data
Ezh1//Ezh2/ RNA-seq data Gene Expression Omnibus (GEO) GSE103685
Deposited RNA-seq, ChIP-seq, RIP-seq datasets This study GSE137491
Experimental Models: Cell Lines
ES-E14TG2a cell line ATCC N/A
ES-E14TG2a Zfc3h1/ #1 This study N/A
ES-E14TG2a Zfc3h1/ #2 This study N/A
ES-E14TG2a Zfc3h1/ #3 This study N/A
Oligonucleotides
sgRNA primers See Table S1 N/A
qRT-PCR primers See Table S2 N/A
Software and Algorithms
ImageJ (1.51h) NIH, Univ. of Wisc. Madison https://imagej.nih.gov/ij/
IGV (2.4.14) Robinson et al., 2011 https://software.broadinstitute.org/software/igv/
cellSens Entry (1.16) Olympus https://www.olympus-lifescience.com/en/
software/cellsens/
Graphpad Prism (7.0a) Graphpad https://www.graphpad.com/scientific-software/
prism/
HISAT (0.1.6.beta) Kim et al., 2015 http://www.ccb.jhu.edu/software/hisat/index.
shtml
bedtools (2.23.0) Quinlan and Hall., 2010 https://bedtools.readthedocs.io/en/latest/
Rsubread (1.32.1) Liao et al., 2013 https://bioconductor.org/packages/release/bioc/
html/Rsubread.html
edgeR (3.24.1) Robinson et al., 2010 https://bioconductor.org/packages/release/bioc/
html/edgeR.html
Trim Galore (0.4.4) Babraham Institute https://www.bioinformatics.babraham.ac.uk/
projects/trim_galore/
EaSeq (1.111) Lerdrup et al., 2016 https://easeq.net/
SAMtools (1.6.1) Li et al., 2009 http://samtools.sourceforge.net/
deepTools (2.5.3) Ramı´rez et al., 2014 https://deeptools.readthedocs.io/en/develop/
Bowtie Langmead and Salzberg., 2012 http://bowtie-bio.sourceforge.net/index.shtml
MACS2 (2.1.1.20160309) Zhang et al., 2008 https://github.com/taoliu/MACS/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Torben
Heick Jensen (thj@mbg.au.dk).
All unique/stable reagents generated in this study are available from the lead contact upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
mES cell culture and differentiation
E14TG2a mouse ESCs (male genotype, XY) were cultured on 0.2% gelatin coated plates in 2i/LIF containing medium (1:1 mix of
Neurobasal (GIBCO) and DMEM/F-12 (GIBCO) supplemented with 1x Pen-Strep (GIBCO), 2 mM Glutamax (GIBCO), 50 mMCell Reports 29, 1800–1811.e1–e6, November 12, 2019 e2
b-mercaptoethanol (GIBCO), 0.1 mM nonessential amino acids (GIBCO), 1 mM sodium pyruvate (GIBCO), 0.5x N2 supplement
(GIBCO), 0.5x B27 supplement (GIBCO), 3 mM GSK3i (CHIR99021), 1 mM MEKi (PD0325901) and Leukemia Inhibitory Factor (LIF;
produced in house)). Cells were passaged every 2-3 days by aspiratingmedium, dissociating cells with 0.25% trypsin-EDTA (GIBCO)
briefly at 37C before the addition of an equal volume of 1x trypsin inhibitor (Sigma) and gentle disruption by pipetting. Cells were
pelleted by centrifugation, washed in 2i-LIF to remove excess trypsin and pelleted again before resuspending and plating 1x106
cells/10 cm plate.
For differentiation into EBs, dissociated cells were washed 2x in Serum-LIF (GMEM (Sigma) supplemented with 10% heat-inacti-
vated fetal bovine serum, 1x Pen-Strep (GIBCO), 2 mMGlutamax (GIBCO), 0.1 mM nonessential amino acids (GIBCO), 1 mM sodium
pyruvate (GIBCO), 50 mM b-mercaptoethanol (GIBCO)) before seeding 1.5x106 cells into 10 cm Petri-dishes containing Serum-LIF
media. Media was changed at days 2, 3, 5 and 7. At day 7, EBs were transferred to 0.2% gelatin coated plates and grown for a further
3 days.
Phase contrast microscopy images were captured using an Olympus IX73 inverted microscope using the cellSens Entry software
(Olympus).
METHOD DETAILS
CRISPR/Cas9 KOs
KO cell lines were generated by CRISPR/Cas9 targeting of Zfc3h1 in WT ESC. Single guide (sg) RNAs (Table S1) were cloned into the
pSPCas9(BB)-2A-GFP vector (pX458, Addgene plasmid ID: 48138) as previously described (Ran et al., 2013) and transfected into ES
cells using Lipofectamine 2000 (Thermo). Single cell cloneswere isolated byGFP sorting using FACS into 0.2%gelatin coated 96well
plates containing 2i/LIF and expanded. KO cloneswere screened bywestern blotting analysis and validated by Sanger sequencing of
amplified genomic DNA around the cut site. Three independent Zfc3h1/ cell lines were derived from expanded single cell clones.
RNA isolation
Total RNA was isolated using the RNeasy Mini Kit (QIAGEN) according to the manufacturer’s instructions or by Trizol extraction
(Thermo) using the standard protocol. For chromatin associated RNA, samples were prepared as previous described (Conrad
and Ørom, 2017).
pA+ RNA purification
pA+ RNA was isolated from nuclear RNA samples using the Dynabeads mRNA Purification Kit (Thermo). For isolation of nuclei, 2x107
cells were resuspended in nuclear isolation buffer (NIB) (10 mM Tris pH 7.4, 150 mMNaCl, 0.15% Igepal CA-630) supplemented with
protease inhibitors and lysed at 4Con a rotating wheel for 5minutes. Lysates were overlaid onto 1mLSucrose buffer (10mMTris pH
7.4, 150 mMNaCl, 24% sucrose) in a DNA LoBind tube (Eppendorf) and nuclei were pelleted for 10 minutes at 2000 x g. Nuclei were
resuspended in 1mL Trizol (Thermo) and RNAwas extracted using the standard protocol. 50 mg of nuclear RNA extracts were heated
to 65C and cooled on ice before incubating with oligo dT(25) Dynabeads (Thermo). Bead complexes were washed twice before
elution in 10 mM Tris pH 7.5 and recovered RNA were assessed using a NanoDrop Lite Spectrophotometer (Thermo).
qRT-PCR analysis
cDNA was prepared from 500 ng of total RNA with TaqMan Reverse Transcription reagents (Thermo) using random hexamers. qRT-
PCR was performed using the LightCycler 480 SYBR Green I (Roche) in technical triplicates. Primers used in qRT-PCR are listed in
Table S2.
RNA-seq library preparation
RNA-seq libraries were prepared from 1 mg of total RNA using the TruSeq Stranded Total RNA library prep kit with RiboZero Gold
(Illumina) according to the manufacturer’s instructions. Three biological replicates from each sample were prepared. RNA integrity
and library quality were assessed on a Bioanalyzer 2000 using RNA Nano and DNA 1000 chips (Agilent), respectively. Libraries
were quantified and normalized for multiplexing using the KAPA library quantification Kit for Illumina (KAPA Biosystems) and
sequenced on an Illumina NextSeq 550 (75-bp, paired-end).
Western blotting analysis
Protein lysates were prepared using TOPEX+ buffer (Riising et al., 2014) (300 mM NaCl, 50 mM Tris-HCl pH 7.5, 0.5% Triton X-100,
1% SDS) freshly supplemented with protease inhibitors, 1 mM DTT and 33.3 U/ml Benzonase (Novagen). SDS-PAGE and western
blotting analysis were carried out according to standard protocols with the antibodies listed in the Key Resources Table and HRP
conjugated secondary antibodies (Vector Laboratories and Agilent). Bands were visualized by Super Signal West Pico chemilumi-
nescent ECL (Thermo) and exposed either on AmershamHyperfilm ECL films (GEHealthcare) and developed (Ferrania Imagine Tech-
nologies) or digitally captured using an Amersham Imager 600 (GE Healthcare). Images were processed and quantified using ImageJ
(Schneider et al., 2012).e3 Cell Reports 29, 1800–1811.e1–e6, November 12, 2019
IP experiments
For whole cell IPs, 1x107 cells/IP were resuspended in HT150 extraction buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 0.5% Triton
X-100) supplemented with protease inhibitors and sheared mechanically using 22 G and 27 G needles sequentially with 6 strokes
each. For nuclear IPs, 1x107 cells/IP were resuspended in nuclear isolation buffer (NIB) (10 mM Tris pH 7.4, 150 mM NaCl, 0.15%
Igepal CA-630) supplemented with protease inhibitors and lysed at 4C on a rotating wheel for 5 minutes. Lysates were overlaid
onto 1 mL Sucrose buffer (10 mM Tris pH 7.4, 150 mM NaCl, 24% sucrose) in a DNA LoBind tube (Eppendorf) and nuclei were pel-
leted for 10 minutes at 2000 x g. Nuclei were resuspended in 250 ml/IP RNA isolation buffer (RIB) (25 mM Tris pH 7.4, 150 mM KCl,
0.5 mM DTT, 0.5% Igepal CA-630) supplemented with protease inhibitors and sheared mechanically using 22 G and 27 G needles
sequentially with 6 strokes each.
Clarified lysates were treated with DNaseI (Thermo) for 20 minutes at 37C before pre-clearing with rabbit IgG (Millipore) and Pro-
tein-A Dynabeads (Thermo) for 2 hours at 4C. Supernatants were incubated with either IgG, SUZ12 (Cell Signaling) or EZH2 (made in
house) antibodies overnight at 4C with Protein-A Dynabeads. Beads were washed 3 times with the respective extraction buffer,
transferring beads to a fresh tube on the final wash. Proteins were eluted by boiling in 1X NuPAGE loading buffer (Invitrogen). 10X
reducing agent (Invitrogen) was added to the supernatants before denaturing for 10 minutes at 95C and proceeding with western
blotting analysis.
Glycerol gradient sedimentation analysis
The glycerol gradient sedimentation analysis was performed as previously described (Chu et al., 2014), with minor modifications.
Briefly, whole cell extracts from 2x108 cells were resuspended in BC100 buffer (5 mM HEPES pH 7.5, 100 mM NaCL, 1 mM
MgCl2, 0.5 mM EGTA, 0.1 mM EDTA, 10% v/v glycerol, 1 mM DTT) supplemented with protease inhibitors, lysed by sonication
(3 3 5 s, amplitude 2) and centrifuged at 14,000 rpm for 20 minutes. Clarified lysates were loaded on 10%–50% (v/v) glycerol gra-
dients prepared in BC100 buffer and centrifuged at 35,000 rpm for 28 hours using aSW41 rotor (Beckman). Gradients were separated
into 18 fractions and protein content was assessed using the Bradford assay (Bio-Rad). Remaining fractions were TCA precipitated,
acetone washed and resuspended in 1x NuPAGE loading buffer (Thermo). Samples were separated by SDS-PAGE and analyzed
either by western blotting analysis or using the Blue Silver modified Neuhoff’s colloidal Coomassie Blue G-250 stain (Candiano
et al., 2004).
RNaseA treatment
Cells were treated with RNaseA as previously described (Beltran et al., 2016). Cells were trypsinised and permeabilised with 0.05%
Tween-20 (Sigma) in PBS for 10 minutes on ice. Cells were washed once, resuspended in PBS and either mock-treated or treated
with 1mgml-1 RNaseA (Thermo) for 30minutes at RTwith gentle agitation. Cells were washed twice with PBS before proceeding with
lysis and IP.
Subcellular fractionation
Cells were separated into cytoplasmic, nuclear and chromatin fractions using the Subcellular Protein Fractionation Kit (Pierce) ac-
cording to the manufacturer’s instructions. Cells were harvested in 1x107 aliquots, split into 2 samples for either whole cell extraction
using TOPEX+ buffer or fractionation. Equivalent lysate volumes were separated by SDS-PAGE and analyzed by western blotting.
RIP experiments
Whole cell IPs were performed as described above with alterations. All buffers were additionally supplemented with 100 U/ml
RiboLock RNase Inhibitor (Thermo). Following overnight IP with IgG, SUZ12 or EZH2 antibodies, beads were washed 3 times with
HT150 buffer, transferring beads to a fresh tube on the final wash. RNA was isolated from the IPs by the addition of 1 mL Trizol, ho-
mogenization and incubating for 1 hour on ice. Beads were removed magnetically and RNA was isolated from Trizol using the stan-
dard protocol.
RIP-seq
Strand specific libraries were prepared from 200 ng RNA isolated in SUZ12 and EZH2 RIP experiments by BGI Tech Solutions
(Europe) according to their lncRNA-seq library preparation protocol. Two biological replicates were prepared from each sample.
RNA integrity was assessed using a BioAnalyzer 2000 (Agilent) using RNA Nano chips. Samples were ribodepleted using Ribo-
Zero (Illumina) and libraries prepared using the TruSeq Stranded mRNA library prep kit (Illumina). Libraries were sequenced on a
BGISEQ-500 (100 bp, paired end).
ChIP experiments
ChIP experiments were carried out according to standard protocols. Briefly, ES cells were cross-linked by the addition of 1% form-
aldehyde (Sigma) in the dish for 10 minutes at RT before quenching with glycine. DNA was sheared to 200 bp fragments by son-
ication using a Biorupter (Diagenode) and validated by agarose gel electrophoresis. ChIPswere carried out using 200 mg of chromatin
and 2-3 mg of the indicated antibodies (Key Resources Table). Libraries for ChIP-seq were prepared using NEBNext Ultra II DNA Li-
brary prep kit (NEB) using AmpureXP beads (Beckman) for size selection. Libraries were assessed on a Bioanalyzer 2000 (Agilent)Cell Reports 29, 1800–1811.e1–e6, November 12, 2019 e4
using High Sensitivity DNA chips and quantified using the Qubit dsDNA HS assay kit (Thermo). Libraries were sequencing on an Illu-
mina NextSeq 550 (75 bp, single end).
QUANTIFICATION AND STATISTICAL ANALYSIS
Processing and analysis of RNA-seq data
Quality control of sequence reads was done using FastQC v0.11.2 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).
Illumina adaptors (as provided with the FastQC tool), low quality bases, the first 12 bases and reads shorter than 25 nt were removed
with Trimmomatic v0.32, using settings ‘‘ILLUMINACLIP:<TrueSeq3_PE_2>:2:30:10 HEADCROP:12 LEADING:22 SLIDING
WINDOW:4:22 MINLEN:25’’ (Bolger et al., 2014). Both paired and unpaired (due to the trimming) reads were mapped using HISAT
v0.1.6.beta (Kim et al., 2015), against the mouse genome (mm10), where a list of GENCODE M12 (Frankish et al., 2019) annotated
splice sites was also provided. HISAT was furthermore run with maximum fragment length set to 1000 and the–rf parameter (for the
upstream/downstream mate orientation), otherwise default settings was used.
To generate visualization, properly paired reads mapping onto unique genomic locations were selected. Genomecov from bed-
tools v2.23.0 (Quinlan and Hall, 2010) was used to calculate strand-specific per-base genome coverage in bedgraph format. Bed-
graph files were converted into bigwig format for using the UCSC Genome Browser Utility ‘bedGraphToBigWig’ (Kent et al.,
2010). Finally, the per base coverage was CPM normalized. Genome browser images are generated from IGV (Robinson et al.,
2011; Thorvaldsdo´ttir et al., 2013)
Paired and uniquely mapped exonic reads for GENCODEM12 genes were counted using featureCounts from the R package Rsu-
bread (1.32.1) (Liao et al., 2013) for individual RNA-seq libraries. RNA-seq read counts for PRC2 KO (Ezh1//Ezh2/) and corre-
sponding WT samples were obtained from the Gene Expression Omnibus (GEO), accession number: GSE103685 (Højfeldt et al.,
2018). Differential expression analysis was performed using the R package edgeR (version 3.24.1) with default parameters (McCarthy
et al., 2012; Robinson et al., 2010). Intronic regions of a gene were defined as regions in the gene body that do not overlap with an
exon from any GENCODE M12 annotated transcript isoform. Intronic reads were counted and differential expression analysis was
performed using the same method as for exonic reads.
Processing and analysis of RIP-seq data
Quality control of sequence reads was done using FastQC v0.11.2. Illumina adaptors, low-quality bases with Phred score lower than
20, and reads shorter than 25 bp were removed using Trim Galore (version: 0.4.4, https://www.bioinformatics.babraham.ac.uk/
projects/trim_galore/); reads were further trimmed using parameters–clip_R1 13–clip_R2 13–three_prime_clip_R1 1–three_prime_
clip_R2 1. Trimmed reads were mapped as described for RNA-seq data processing. BAM alignment files were further processed
to select uniquely mapped and properly paired reads using SAMtools (version 1.6.1) (Li et al., 2009). Duplicated reads were removed
using MarkDuplicates (version: 2.8.1) from GATK (McKenna et al., 2010) with default settings and processed BAM files were used for
downstream analysis. The strand specific genomic coverage was calculated using bamCoverage from deepTools (Ramı´rez et al.,
2014). Raw reads for GENCODEM12 genes were counted using the samemethod as for RNA-seq, and differential analysis was per-
formed using edgeR. To calculate the enrichment of transcripts pulled down by SUZ12 and EZH2 IPs in Zfc3h1/ compared to WT,
contrast in the differential analysis was made as (Zfc3h1/ IP – Zfc3h1/ input) – (WT IP – WT input) and the enrichment score was
defined as log2 fold change calculated from the contrast.
Processing and analysis of ChIP-seq data
Reads were mapped onto the mouse (mm10) genome with Bowtie (Langmead and Salzberg, 2012), selecting only hits with the best
stratum with up to two mismatches in the seed and reporting up to four good alignments per read. Only two copies of identical reads
were kept. The fragment sizes could be deduced using the ChIP-Cor tool (Ambrosini et al., 2016). Reads were shifted to the center of
their fragment by half of the deduced fragment size. Genomecov frombedtools v2.23.0 (Quinlan andHall, 2010) was used to calculate
strand specific per base genome coverage in bedgraph format. Bedgraph files were converted into bigwig format for using the UCSC
Genome Browser Utility ‘bedGraphToBigWig’ (Kent et al., 2010). Finally, the per base coverage was CPM normalized.
For global MA plots, ChIP signals from all libraries were quantified on genomic windows of 2 kb sliding by 500 bp using the UCSC
Genome Browser Utility ‘bigWigAverageOverBed’ (Kent et al., 2010). SUZ12 peaks were called using MACS2 (Zhang et al., 2008)
(version 2.1.1.20160309) with parameters–qvalue 0.05–broad–broad-cutoff 0.3, ENCODE blacklisted peaks (ENCODE Project Con-
sortium, 2012) and low quality peaks (-log10(qvalue)% 1) were filtered out. Consistent SUZ12 peaks between Zfc3h1
/ replicates
were defined as peaks overlapping in at least two replicates. A single SUZ12 reference peak set for WT and Zfc3h1/was obtained
by pooling SUZ12 peaks of WT and consistent SUZ12 peaks of Zfc3h1/ andmerging overlapping peak regions into a single region
using mergeBed from bedtools (v2.23.0). Raw reads of H3K27me3 and SUZ12, for SUZ12 peaks in the reference peak set, were
obtained using featureCounts from the R package Rsubread (1.32.1), a pseudocount of 1 was added when normalizing raw read
counts to the library size. log2FC values were calculated between mean values of the normalized read counts from Zfc3h1
/ rep-
licates and the normalized read counts from WT. For mean signal plots, genomic coverage from bigWig files was calculated using
computeMatrix from deepTools (version 2.5.3) (Ramı´rez et al., 2014). Regions without read coverage in bigWig files were treated
as 0, mean values from the replicates were calculated andmean values at each position were plotted. For the heatmap, a list of genese5 Cell Reports 29, 1800–1811.e1–e6, November 12, 2019
overlapping with at least one SUZ12 peak from the reference peak set was obtained, H3K27me3 and SUZ12 were quantified in the
gene bodies, log2FC values of H3K27me3 and SUZ12 between Zfc3h1
/ and WT were calculated using the method described
above, and log2FC values of gene exonic expression were computed from the differential expression analysis of RNA-seq described
above.
DATA AND CODE AVAILABILITY
All high-throughput RNA-seq, ChIP-seq and RIP-seq datasets generated during this study are available at the Gene Expression
Omnibus (GEO) under accession code GSE137491.Cell Reports 29, 1800–1811.e1–e6, November 12, 2019 e6
